Santhera Pharmaceuticals Holding AG Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG

SANN

Peringkat dalam Saham #16102
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company,... Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company’s lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmonary diseases. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.
Harga Saham
$19.25
Terakhir disinkronkan: 2026-10-20
Kapitalisasi Pasar
$294.54M
Perubahan (1 hari)
2.64%
Perubahan (1 tahun)
50.03%
Negara
CH
Perdagangan Santhera Pharmaceuticals Holding AG (SANN)

Kategori

Healthcare
Riwayat hasil dividen untuk Santhera Pharmaceuticals Holding AG (SANN)
Hasil dividen (TTM) dari Santhera Pharmaceuticals Holding AG (simbol saham: SANN) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Santhera Pharmaceuticals Holding AG (SANN) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
Perusahaan Hasil Dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.17%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL